Adenosine as an antiarrhythmic agent

American Journal of Cardiology

Volumn 79, Issue 12 A, 1997, Pages 30-37

  Wilbur, Sabrina L ^a   Marchlinski, Francis E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT; DIPYRIDAMOLE; XANTHINE DERIVATIVE;

ANGINA PECTORIS; ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; DYSPNEA; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; REENTRY TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CHILD; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TACHYCARDIA, SINOATRIAL NODAL REENTRY; TACHYCARDIA, VENTRICULAR; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 0030737752     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00261-0     Document Type: Conference Paper

References (69)

1. Drury AN, Szent-Gyorgyi A. The physiologic activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol (Lond). 68:1929;213-237.
2. Honey RM, Ritchie WT, Thomson WAR. The action of adenosine upon the human heart. Q J Med. 23:1930;485-489.
3. Belardinelli L, Linden J, Berne R. The cardiac effects of adenosine. Prog Cardiovas Dis. 32:1989;73-97.
4. Lerman BB, Beladinelli L. Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation. 83:1991;1499-1509.
5. Haleen SJ, Evans DB. Selective effects of adenosine receptor agonists upon coronary resistance and heart rate in isolated working rabbit hearts. Life Sci. 36:1985;127-137.
6. 1 receptors. IRCS Med Sci. 9:1981;447.
7. Visentin S, Wu S-N, Belardinelli L. Adenosine-induced changes in atrial action potential: Contribution of Ca and K currents. Am J Physiol. 258:1990;H1070-1078.
8. Dobson JG Jr. Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3′,5′-monophosphate formation in glycogen phosphorylase activity in rat heart muscle. Circ Res. 43:1978;785-792.
9. West GA, Belardinelli L. Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pflugers Arch. 403:1985;75-81.
10. Lokhandwala MF. Inhibition of cardiac sympathetic neurotransmission by adenosine. Eur J Pharmacol. 60:1979;353-357.
11. Belardinelli L, Isenberg G. Actions of adenosine and isoproterenol on isloated mammalian ventricular myocytes. Circ Res. 53:1983;287-297.
12. Jakob H, Odert H, Rupp J, Nawrath H. Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle. Br J Pharmacol. 97:1989;1199-1208.
13. Biaggioni I, Killian TJ, Mosqueda-Garcia R, Robertson RM, Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation. 83:1991;1668-1675.
14. Belardinelli L, Giles WR, West A. Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol (Lond). 405:1988;615-633.
15. Englestein Ed, Lippman N, Stein KM, Lerman BB. Mechanism-specific effects of adenosine on atrial tachycardia. Circulation. 89:((6)):1994;2645-2654.
16. DiMarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, Bellardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol. 6:1985;417-425.
17. Epstein Ml, Belardinelli L. Failure of adenosine to terminate focal atrial tachycardia. Pediatr Cardiol 1993;14:199-121.
18. Till J, Shinebourne EA, Rigby M, Clark B, Ward DE, Rowland E. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J. 62:1989;204-211.
19. Shenasa J, Kanter RJ, Hamer ME, Sorrentino RA, Sanders WE, Green-field RA, Page RL, Wharton JM. Reappraisal of the efficacy of adenosine for termination of ectopic atrial tachycardia. (Abstr.). J Am Coll Cardiol. 21:1993;456A.
20. Shenasa H, Greenfield RA, Johnson EE, Sorrentino RA, Wharton JM. Does adenosine differentiate sinoatrial reentrant tachycardia from ectopic atrial tachycardia? (Abstr.). Circulation. 88:((suppl I)):1993;I-396.
21. Perelman MS, Krikler DM. Termination of focal atrial tachycardia by adenosine triphosphate. Br Heart J. 58:1987;528-530.
22. Belardinelli L, Shryock J, West GA, Clemo HF, DiMarco JP, Berne RM. Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation. 70:1984;1083-1091.
23. DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L. Adenosine: electro-physiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation. 68:1983;1254-1263.
24. Manolis AS, Estes AM. Supraventricular tachycardia mechanisms and therapy. Arch Intern Med. 147:1987;1706-1716.
25. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med. 113:1990;104-110.
26. DiMarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, Belardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol. 6:1985;417-425.
27. Belhassen B, Glick A, Laniado S. Comparative clinical and electrophysiologic effects on adenosine triphosphate and verapamil on paroxsymal reciprocating junctional tachycardia. Circulation. 77:1988;795-805.
28. Rankin AC, Oldroyd KG, Chong E, Rae AP, Cobbe SM. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J. 62:1989;195-203.
29. Garratt C, Linker N, Griffith M, Ward D, Camm AJ. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia. Am J Cardiol. 64:1989;1310-1316.
30. Rinne C, Sharma AD, Klein GJ, Yee R, Szabo T. Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction. Am Heart J. 115:1988;1042-1047.
31. Li HG, Morillo CA, Zardini M, Thakur RK, Yee R, Klein GJ. Effect of adenosine or adenosine triphosphate on antidromic tachycardia. J Am Coll Cardiol. 24:((3)):1994;728-731.
32. Fishberger SB, Saul JP, Triedman JK, Epstein MR, Walsh EP. Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radio-frequency catheter ablation. Am J Cardiol. 75:1995;1278-1281.
33. Garratt CJ, Griffith MJ, O'Nunain S, Ward DE, Camm AJ. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections. Circulation. 84:1991;1962-1968.
34. Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco JP. Adenosine-sensitive ventricular tachycardia: Evidence suggesting cyclic AMP-mediated triggered activity. Circulation. 74:1986;270-280.
35. Wilber DJ, Baerman J, Olshansky B, Kall J, Kopp D. Adenosine-sensitive ventricular tachycardia-clinical characteristics and response to catheter ablation. Circulation. 87:((1)):1993;126-134.
36. Klabunde RE. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol. 93:1983;21-26.
37. Ontyd J, Schrader J. Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr. 307:1984;404-409.
38. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 25:1989;C799-806.
39. McIntosh-Yellin NL, Drew BL, Scheinman MM. Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia. J Am Coll Cardiol. 22:((3)):1993;741-745.
40. Rotmensch H, Rotmensch S, Elkayam U. Management of cardiac arrhythmias in pregnancy. Drugs. 33:1987;623-633.
41. Afridi I, Moise KJ, Rokey R. Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White Syndrome. Obstet Gynecol. 80:((3)):1992;481-483.
42. Mason BA, Ricci-Goodman J, Koos BJ. Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. Obstet Gynecol. 80:((3)):1992;478-480.
43. Sellers T, Kirchhoffer J, Modesto T. Adenosine: A clinical experience and comparison with verapamil for termination of supraventricular tachycardias. Pelleg A, Michelson E, Dreifus L. Cardiac Electrophysiology and Pharmacology of Adenosine and ATP/G: Basic and Clinical Aspects. 1987;283-299 Liss, New York.
44. Klein V, Repke JT. Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Obstet Gynecol. 63:1984;16S-18S.
45. Clarke B, Rowland E, Barnes PJ, Till J, Ward DE, Shinebourne EA. Rapid and safe termination of supraventricular tachycardia in children by adenosine. The Lancet. i:1987;299-301.
46. Till J, Shinebourne EA, Rigby ML, Clarke B, Ward DE, Rowland E. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J. 62:1989;204-211.
47. Rossi AF, Steinberg LG, Kipel G, Golinko RJ, Griepp RB. Use of adenosine in the management of perioperative arrhythmias in the pediatric cardiac intensive care unit. Crit Care Med. 20:1992;1107-1111.
48. Overholt ED, Rheuban KS, Gutgesell HP, Lerman BB, DiMarco JP. Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol. 61:1988;336-340.
49. Epstein ML, Kiel EA, Victorica BE. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics. 75:1985;737-740.
50. Kirk CR, Gibbs JL, Thomas R, Radley-Smith R, Qureshi SA. Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child. 62:1987;1265-1282.
51. Bush A, Busst CM, Clarke B, Barnes PJ. Effect of infused adenosine on cardiac output and systemic resistance in normal subjects. Br J Pharmacol. 27:1989;165-171.
52. Watt AH, Routledge PA. Adenosine stimulates respiration in man. Br J Clin Pharmacol. 20:1985;503-506.
53. Watt AH, Reid PG, Stephens MR, Routledge PA. Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body? Br J Clin Pharmacol. 61:1987;779-786.
54. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res. 61:1987;779-786.
55. Cushley MG, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 14:1985;161-165.
56. Taviot B, Pacheco Y, Coppere B, Pirollet B, Rebaudet P, Perrin-Fayolle M. Bronchospasm induit par l'injection d'adenosine chez un asthmatique. (Letter). Presse Med. 15:1986;1103.
57. Crea F, Pupita G, Galassi AR, El-Tamimi H, Kaski JC, Davies G, Maseri A. Role of adenosine in pathogenesis of anginal pain. Circulation. 81:1990;164-172.
58. Sylven C, Jonzon B, Brandt R, Beermann B. Adenosine provoked angina pectoris-like pain-time characteristics, influence of autonomic blockade and naloxone. Eur Heart J. 8:1987;738-743.
59. Reed R, Falk JL, O'Brien J. Untoward reaction to adenosine therapy for supraventricular tachycardia. Am J Emerg Med. 9:((6)):1991;566-570.
60. Brodsky MA, Hwang C, Hunter D, Chen P, Smith D, Ariani M, Johnston WD, Allen BJ, Chun JG, Gold CR. Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J. 130:1995;564-571.
61. Watt AH, Bernard MS, Webster J, Passani SL, Stephens MR, Routledge PA. Intravenous adenosine in the treatment of supraventricular tachycardia: a dose ranging study and interaction with dipyridamole. Br J Clin Pharmacol. 21:1986;227-230.
62. Botteron GW, Smith JM. Spatial and temporal inhomogeneity of adenosine's effect on atrial refractoriness in humans: using atrial fibrillation to probe atrial refractoriness. J Cardiovasc Electrophysiol. 5:1994;477-484.
63. Belardinelli L, Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol. 244:1983;H734-737.
64. Munoz A, Leenhart A, Sassine A, Galley P, Puech P. Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia. Eur Heart J. 5:1984;735-738.
65. Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J. 69:1993;263-265.
66. Slade AKB, Garratt CJ. Proarrhythmic effect of adenosine in a patient with atrial flutter. Br Heart J. 70:1993;91-92.
67. Wesley RC, Turnquest P. Torsades de pointes after intravenous adenosine in the presence of prolonged QT syndrome. Am Heart J. 123:((3)):1992;794-796.
68. Harrington GR, Froelich EG. Adenosine-induced torsades de pointes. Chest. 103:1993;1299-1301.
69. Ben-Sorek ESW, Wiesel J. Ventricular fibrillation following adenosine administration. Arch Intern Med. 153:1993;2701-2702.